Clinical trial
Methodology Study of Novel Electrophysiological, Physical, and Imaging Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis
NCT02611674 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methodology Study of Novel Electrophysiological, Physical, and Imaging Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 6, 2016
- Completion date
- August 1, 2019
- Enrollment
- 138 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.